CLEVELAND --The global medical device and diagnostics (MD&D) industry generated nearly $286 billion in revenues in 2007, with continued gains in 2008 reflecting both organic growth and currency fluctuations. However, as of late 2008, sales have declined in selected markets due to cutbacks in hospital budgets and reductions in hospital admissions and elective surgeries. This situation is being exacerbated by the global financial crisis, which is placing severe cost constraints on health care systems as economic growth stagnates. Although demographics and the growing prevalence of age-related diseases would appear to support continued, even substantial market gains, MD&D suppliers are understandably concerned about the timing and magnitude of market recovery as competition intensifies for increasingly scarce health care funds.

The new report published

by HRI—entitled “Opportunities in Global Medical Devices and Diagnostics” and distributed exclusively by Life Science Intelligence—provides “must-have” expert analysis of the critical trends and developments impacting the MD&D market through 2012. The 572-page report provides individual market, geographic and competitive assessments for 19 major technology segments (90 individual product markets), including: cardiovascular technologies; in vitro diagnostics; orthopedics and spine; diagnostic imaging equipment and consumables; urology/renal; wound management; dental; ophthalmic surgery; critical care; energy-based therapies; and endoscopy, among others. These are complemented by statistics and discussions of the 10 major clinical applications driving use of MD&D products.

View details at: lifescienceintelligence.com/market-reports-page.php?id=HRI-252